Rhizomycosis infection in the basal ganglia

Archives of Neurology

Volumn 64, Issue 1, 2007, Pages 134-135

  Pandian, Jeyaraj Durai ^b   McCarthy, James S ^b   Goldschlager, Tony ^b   Robertson, Thomas ^b   Henderson, Robert D ^a  

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ADULT; ARTICLE; BASAL GANGLION; BRAIN BIOPSY; CASE REPORT; HOSPITAL ADMISSION; HUMAN; MALE; MUCORMYCOSIS; NEUTROPHIL CHEMOTAXIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RHIZOMUCOR; RHIZOMYCOSIS;

ADULT; BASAL GANGLIA; BASAL GANGLIA DISEASES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MUCORMYCOSIS; RHIZOMUCOR;

EID: 33846071466     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.1.134     Document Type: Article

References (5)

1. Hameroff SB, Eckholdt JW, Lindenberg R. Cerebral phycomycosis in a heroin addict. Neurology. 1970;20:261-265.
2. Hopkins RJ, Rothman M, Fiore A, Goldblum SE. Cerebral mucormycosis associated with intravenous drug use: three case reports and review. Clin Infect Dis. 1994;19:1133-1137.
3. Huang E, Ong WY, Connor JR. Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience. 2004;128:487-496.
4. McNab AA, McKelvie P. Iron overload is a risk factor for zygomycosis. Arch Ophthalmol. 1997;115:919-921.
5. Verdonck AK, Boelaert JR, Gordts BZ, Van Landuyt HW. Effect of ferrioxamine on the growth of Rhizopus. Mycoses. 1993;36:9-12.